Caris Life Sciences, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 14 →Insiders3 insiders bought $611,790 in 3 open-market buys. 1 insider sold $1.7M, all 2 sales on a 10b5-1 plan.→HoldersFMR 10.9%J. H. Whitney Equity Partners VI 4.0%Coatue 3.5%→PeersClosest companies: TEM, GH, BLLN→
From the filings
Figures
- Revenue
- $989.6Mlast 12 months
- Net income
- $105.1Mlast 12 months
- Operating cash flow
- $147.4Mlast 12 months
- Cash and equivalents
- $819.9Mat the last balance sheet
- Total debt
- $393.2Mat the last balance sheet
- Shares outstanding
- 282.6M shareson issue